title: Cardiac rhythm device surgery with uninterrupted oral anticoagulation.
abstract: Current guidelines recommend interrupting anticoagulation and bridging therapy with heparin or low-molecular-weight heparin for cardiac rhythm device surgeries in patients with high thrombotic risk. However, there are some studies that suggest continuing warfarin may be safe. The study by Birnie et al. investigates this important clinical question in a randomized controlled trial setting. They randomly assigned 681 patients with high thrombotic risk (5% or more per year), in 18 centers, to receive either stopping warfarin combined with heparin bridging (standard of care) or continued uninterrupted warfarin therapy for cardiac rhythm device surgery. The trial was terminated after a second prespecified interim analysis by the data and safety monitoring board. Clinically significant device-pocket hematoma was noted in 12 out of 343 patients (3.5%) in the uninterrupted warfarin group, compared with 54 out of 338 (16.0%) in the heparin-bridging group (relative risk: 0.19; 95% CI: 0.10-0.36; p < 0.001). Uninterrupted warfarin was associated with better patient satisfaction, and there was no significant difference in thromboembolic or surgical complications between the two groups. These results demonstrate that device surgeries can be safely performed with continued warfarin, and bridging with heparin is associated with high risk of device-pocket hematoma.
authors.affiliation: Department of Cardiology, Loma Linda University Medical Center, Loma Linda, CA, USA.
authors.forename: Gaurav
authors.initials: G
authors.lastname: Tyagi
authors.forename: Sudha M
authors.initials: SM
authors.lastname: Pai
authors.forename: Ramdas G
authors.initials: RG
authors.lastname: Pai
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D017147:Defibrillators, Implantable; D005260:Female; D006406:Hematoma / Q000209:etiology*; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D010138:Pacemaker, Artificial; D014859:Warfarin / Q000008:administration & dosage*
chemical_list: D000925:Anticoagulants; D014859:Warfarin; D006493:Heparin